Press Releases

Press Releases

Research and Markets has announced the addition of the "Dermatomyositis Global Clinical Trials Review, H2, 2016" clinical trials to their offering. Dermatomyositis Global Clinical Trials Review, H2, 2016 Summary The author's clinical trial report, Dermatomyositis Global Clinical Trials Review, H2, 2016" provides an overview of Dermatomyositis clinical trials scenario. This…

Press Releases

Research and Markets has announced the addition of the "Global Halal Pharmaceuticals Market Analysis & Trends - Product Type, Drug Classes, Source Material - Forecast to 2025" report to their offering. Some of the prominent trends that the market is witnessing include growing need for certified medicines is propelling regulatory…

Press Releases

Neurotrope, Inc., a company focused on developing drugs to treat neurodegenerative diseases including Alzheimer's disease, today issued a statement on Eli Lilly's experimental drug solanezumab.  Lilly stated that, based upon results from its recent Phase 3 clinical trial, solanezumab failed to improve cognition of patients with mild Alzheimer's disease. Dr.…

Press Releases

Juno Therapeutics, Inc., a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced that it has voluntarily placed on hold the Phase II clinical trial of JCAR015 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia, known as the…

Press Releases

WuXi Biologics, a WuXi AppTec group company and a leading open-access R&D capability and technology platform company dedicated to expediting global biologics development, and Prima Biomed Ltd. (Prima), an ASX (PRR) and Nasdaq (PBMD) listed company developing IMP321, a recombinant soluble LAG-3 protein and other LAG-3 related products for use…

Press Releases

Shire plc announced that it will expand its operations in Cambridge, Massachusetts, establishing a rare disease innovation hub and increasing its footprint in the heart of Kendall Square. Shire and BioMed Realty have signed a lease for a 343,000-square-foot building at 500 Kendall Street. Shire's lease begins in Q3, 2018,…

Press Releases

Absorption Systems, a world leader in novel test systems for drug transporters, announces the renewal of a technology licensing deal with Biogen. After years of contract testing by Absorption Systems using MDR1-MDCK cells, Biogen licensed the technology associated with the test system from Absorption Systems in October 2015 and is…

Press Releases

TKL Research, a dermatology specialty clinical research organization (CRO), announced today that it has signed an agreement to sell its Clinical Trials Division (CTD) to QuintilesIMS. Upon closing, TKL’s CTD will become part of Novella Clinical, a Quintiles company. Moving forward, TKL Research will retain its Research Clinics Division (RCD)…

Tuesday, Nov 22, 2016
Press Releases

Boost your business in 2017 by presenting your solutions to the top pharmaceutical and biotechnology decision makers in Central Eastern Europe! TEG -  organizer of the most important pharmaceutical and and biotechnology business summit in CEE Pharm Connect Congress, with the support of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) -…

Press Releases

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT:IMUC) announced the presentation of updated immune monitoring data from the phase 2 trial of ICT-107 in patients with newly diagnosed glioblastoma. Also presented were updated long-term survival data from the phase 1 trial of ICT-107. ICT-107 is a dendritic cell-based immunotherapy targeting multiple tumor-associated…